USANA Health Sciences
USNA | NYSE
$13.54
+$0.30 (+2.27%)
At close: Nov 16, 2026, 4:00 PM ET
$13.81
+$0.27 (+1.99%)
After-hours:
Nov 16, 2026, 4:05 PM ET
USANA Health Sciences Company Profile
Company profile explainedCompany Profile
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Key Executives
| Name | Position |
|---|---|
| Kevin G. Guest | CEO & Executive Chairman |
| G. Douglas Hekking | Chief Financial Officer |
| Joshua Foukas | Chief Legal Officer, General Counsel & Corporate Secretary |
| Peter Benedict | Chief Information Officer |
| Walter Noot | Chief Operating Officer |
| Brent L. Neidig | Chief Commercial Officer |
| John Cuomo | Executive Director of Product Development & Technology |
| Kathryn Armstrong | Chief Scientific Officer |
| Myron W. Wentz | Founder & Chairman Emeritus |
| Patrique Richards | Executive Director of Investor Relations & Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 23, 2026 | 4 | Filing |
| Oct 23, 2026 | 4 | Filing |
| Oct 23, 2026 | 4 | Filing |
| Oct 23, 2026 | 4 | Filing |
| Oct 23, 2026 | 4 | Filing |
| Oct 23, 2026 | 4 | Filing |
| Oct 23, 2026 | 4 | Filing |
| Oct 05, 2026 | 8-K | Current Report |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 10-Q | Quarterly Report |
USANA Health Sciences
| Country | United States |
| IPO Date | Apr 4, 1994 |
| Industry | Packaged Foods |
| Sector | Consumer Defensive |
| Employees | 1,570 |
| CEO | Kevin G. Guest |
Contact Details
3838 West Parkway Boulevard Salt Lake City,
Utah 84120 United States
Stock Details
| Ticker Symbol | USNA |
| Exchange | NYSE |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000896264 |
| CUSIP Number | 90328M107 |
| ISIN Number | US90328M1071 |
| SIC Code | 2833 |
Add to Watchlist
Select watchlists to add or remove USNA